Scientists across the University of California system are taking aim at breast cancer. Along with developing better detection methods, researchers are making advances in imaging techniques and tapping into advances in genetics and immunology to develop more refined approaches to treatment.

There’s good news on the breast cancer front: Advances in medicine are helping more women than ever survive a breast cancer diagnosis.

Early-stage breast cancer patients whose tumors carry genetic markers associated with a low risk of disease recurrence may not need to undergo chemotherapy, suggests a new study that employed a test devised by a UC San Francisco researcher.

The ideal interval for breast cancer screening depends on combined assessments of each woman’s breast cancer risk and her breast density, according to a new study led by UC San Francisco and University of Wisconsin (UW) researchers. The research team, members of two nationwide breast ...

Karla Kerlikowske, MD, a co-principal investigator of the Breast Cancer Surveillance Consortium(BCSC), is part of the team awarded $7.5 million by the Patient-Centered Outcomes Research Institute(PCORI) board of governors to determine the effectiveness of two supplemental breast screening and diagnostic workup strategies.

Cancer specialists from UC San Francisco will share information on advances in research during the annual meeting of the American Society of Clinical Oncology (ASCO), one of the world’s most prestigious gatherings of oncology professionals.